PTGS1 and malignant colon neoplasm: Interestingly, Li et al. in the same work identified a novel selective COX-1 inhibitor, 6-C-(E-phenylethenyl)-naringenin, a derivative of the flavonoid naringenin, also showing its chemopreventive efficacy in a colon cancer xenograft model.